Axogen, Inc.
AXGN· Nasdaq
Released Mar 1, 2017, after the close
10-K filed Mar 1, 2017, 60 days after period end · 0001558370-17-001241
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016 | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $11.41M | $7.81M | $4.79M | $2.98M |
| Net Income | -$5.63M | -$3.61M | -$6.49M | -$4.11M |
Axogen, Inc. · CIK 805928 · Engraved from SEC EDGAR
| EPS Diluted | -$0.17 | — | — | — |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.